See more : Puda Coal, Inc. (PUDA) Income Statement Analysis – Financial Results
Complete financial analysis of Verano Holdings Corp. (VRNOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Verano Holdings Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Silver Wolf Exploration Ltd. (SWLFF) Income Statement Analysis – Financial Results
- Shandong Hualu-Hengsheng Chemical Co., Ltd. (600426.SS) Income Statement Analysis – Financial Results
- Huaren Pharmaceutical Co., Ltd. (300110.SZ) Income Statement Analysis – Financial Results
- LG Chem, Ltd. (051915.KS) Income Statement Analysis – Financial Results
- Tycoon Group Holdings Limited (3390.HK) Income Statement Analysis – Financial Results
Verano Holdings Corp. (VRNOF)
About Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 938.45M | 879.41M | 737.85M | 290.79M | 85.66M |
| Cost of Revenue | 463.25M | 456.35M | 403.29M | 118.29M | 38.86M |
| Gross Profit | 475.21M | 423.06M | 334.56M | 172.50M | 46.80M |
| Gross Profit Ratio | 50.64% | 48.11% | 45.34% | 59.32% | 54.63% |
| Research & Development | 0.00 | 1.17M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 179.54M | 233.83K | 57.96K |
| Selling & Marketing | 0.00 | 0.00 | 8.64M | 0.00 | 1.20M |
| SG&A | 331.93M | 356.57M | 188.18M | 233.83K | 57.96K |
| Other Expenses | 58.49M | 116.15M | 41.78M | 0.00 | 0.00 |
| Operating Expenses | 390.12M | 472.72M | 229.97M | 233.83K | 57.96K |
| Cost & Expenses | 853.36M | 929.07M | 633.25M | 233.83K | 57.96K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 59.79M | 49.43M | 24.27M | 13.31M | 5.64K |
| Depreciation & Amortization | 151.63M | 150.33M | 96.24M | 10.01M | 9.60M |
| EBITDA | 239.22M | 36.35M | 169.50M | 97.76M | 5.58M |
| EBITDA Ratio | 25.49% | 15.22% | 28.94% | -0.08% | -0.07% |
| Operating Income | 84.78M | -16.46M | 107.68M | -233.83K | -57.96K |
| Operating Income Ratio | 9.03% | -1.87% | 14.59% | -0.08% | -0.07% |
| Total Other Income/Expenses | -56.99M | -2.27M | -19.88M | -9.85M | -5.64K |
| Income Before Tax | 27.80M | -163.40M | 91.96M | -249.02K | -63.60K |
| Income Before Tax Ratio | 2.96% | -18.58% | 12.46% | -0.09% | -0.07% |
| Income Tax Expense | 145.15M | 105.47M | 104.13M | 15.19K | -3.26K |
| Net Income | -117.35M | -268.87M | -12.17M | -264.22K | -60.34K |
| Net Income Ratio | -12.50% | -30.57% | -1.65% | -0.09% | -0.07% |
| EPS | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | -0.34 | -0.81 | -0.04 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 344.07M | 331.41M | 287.54M | 290.00M | 290.00M |
| Weighted Avg Shares Out (Dil) | 342.77M | 331.41M | 290.44M | 290.00M | 290.00M |
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
Shares of both U.S. and Canadian cannabis stocks moved up on Friday after President Joe Biden mentioned the federal government's current effort to potentially reclassify the plant under federal law in his State of the Union speech.
These Marijuana Stocks To Buy Could Make You Profits?
Marijuana stock investors have been riding the moment wave. What this means is that since the start of the new year, there have been several reasons why momentum is building. To start it is the speculation of what will take...
Verano Holdings: Temporary Setbacks, But Potential For Long-Term Gains
Verano reported positive Q4 2023 results with robust growth in New Jersey, Maryland and Florida. Due to delay in 10-K filing, VRNOF price fell sharply by almost 10% since the morning of February 29, 2023. Verano's business is similar to...
Verano Holdings Corp. (VRNOF) Q4 2023 Earnings Call Transcript
Verano Holdings Corp. (VRNOF) Q4 2023 Earnings Call Transcript
Trulieve, Green Thumb Industries, Verano beat revenue estimates as more states roll out legal cannabis sales
Trulieve Cannabis Corp., Green Thumb Industries Inc. and Verano Holdings Corp. all topped revenue estimates for the fourth quarter, as the cannabis companies opened new stores and more states rolled out medical and adult-use programs.
Verano Announces Fourth Quarter and Full Year 2023 Financial Results
Record Revenue of $938 Million Increased 2023 Net Cash Provided by Operating Activities by 16% to $110 Million Generated $73 million in Free Cash Flow 1 for 2023, Meeting Guidance
3 Cannabis Stocks Blazing a Trail to Legalization
As excitement builds, U.S. federal agencies are looking to revise cannabis regulations. Support for cannabis legalization has surged to unprecedented levels, which bodes incredibly well for cannabis stocks.
High Potential: Leading US Cannabis Companies to Watch Before March 2024
The US marijuana sector is poised for significant expansion as legislative changes unfold. With more states legalizing cannabis for medicinal and recreational use, the industry's growth trajectory looks promising. Overall, this uptrend will fuel investor interest in top US marijuana...
Cannabis Investing: Top Marijuana Stock Picks For March 2024
The cannabis industry is comprised of many niches and opportunities. Inside the cannabis industry, you have cultivators, dispensary owners, packaging and labeling companies, and grow stores. The several niches of the many are the core focus and means to operate...
The 3 Best Cannabis Stocks to Buy in February 2024
With even the federal government considering de-scheduling marijuana, it seems many Americans are warming up to the budding industry. As predictions for marijuana revenues reach $60 billion this year, the potential for investor returns can't be ignored.
Source: https://incomestatements.info
Category: Stock Reports